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Abstract
Background: The change of malaria case-management policy in Kenya to recommend universal parasitological diagnosis
and targeted treatment with artemether-lumefantrine (AL) is supported with activities aiming by 2013 at universal coverage
and adherence to the recommendations. We evaluated changes in health systems and case-management indicators
between the baseline survey undertaken before implementation of the policy and the follow-up survey following the first
year of the implementation activities.
Methods/Findings: National, cross-sectional surveys using quality-of-care methods were undertaken at public facilities.
Baseline and follow-up surveys respectively included 174 and 176 facilities, 224 and 237 health workers, and 2,405 and 1,456
febrile patients. Health systems indicators showed variable changes between surveys: AL stock-out (27% to 21%; p=0.152);
availability of diagnostics (55% to 58%; p=0.600); training on the new policy (0 to 22%; p=0.001); exposure to supervision
(18% to 13%; p=0.156) and access to guidelines (0 to 6%; p=0.001). At all facilities, there was an increase among patients
tested for malaria (24% vs 31%; p=0.090) and those who were both tested and treated according to test result (16% to 22%;
p=0.048). At facilities with AL and malaria diagnostics, testing increased from 43% to 50% (p=0.196) while patients who
were both, tested and treated according to test result, increased from 28% to 36% (p=0.114). Treatment adherence
improved for test positive patients from 83% to 90% (p=0.150) and for test negative patients from 47% to 56% (p=0.227).
No association was found between testing and exposure to training, supervision and guidelines, however, testing was
significantly associated with facility ownership, type of testing, and patients’ caseload, age and clinical presentation.
Conclusions: Most of the case-management indicators have shown some improvement trends; however differences were
smaller than expected, rarely statistically significant and still leaving a substantial gap towards optimistic targets. The
quantitative and qualitative improvement of interventions will ultimately determine the success of the new policy.
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Introduction
Universal parasitological testing and subsequent treatment of
test positive patients with artemisinin-based combination
therapy (ACT) are the critical components of the latest
international recommendations for malaria case-management
[1]. However, the success of the implementation of the new
case-management policy is dependent upon series of factors of
which availability of commodities at health facilities and case-
management practices are of vital importance to ensure cost-
benefit of the diagnostics and ACT based case-management
strategies [2–4].
In 2009, Kenya launched the new 2009–2017 National Malaria
Strategy (NMS) whose case-management mainstay is parasitolog-
ical testing of all febrile patients across all age groups and areas of
malaria endemicity and treatment of only test positive patients
with nationally recommended ACT – artemether-lumefantrine
(AL) [5,6]. Simultaneously, by 2013, the new NMS specified
programmatic directions to ensure universal availability of AL and
malaria diagnostics as well as universal health worker’s adherence
to the new malaria case-management guidelines [7]. In this
manuscript we report levels and changes in the availability of
commodities and malaria case-management practices between two
national health facility surveys; the baseline survey undertaken at
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NMS, and the follow-up survey undertaken at the end of 2010,
following the first year of the implementation activities.
Methods
Description of the key 2010 implementation activities
The main implementation activity during 2010 was a
nationwide training for front-line health workers on the new
case-management policy. The training took place between April
and September 2010. The training was implemented following the
training-of-trainers two-stage cascade format, starting at the
national level by training representatives of 10 organizations
who, in 110 training sessions, trained 4,807 health workers in the
public sector nationwide. The training was done outside of health
facilities, in the form of 3-day workshops according to standard-
ized training curriculum [8]. One day was devoted to the
management of uncomplicated malaria. The teaching modalities
included lectures and theoretical case scenarios. The training was
based on the recommendations in the new guidelines for health
workers which were disseminated to health workers after the
training following the launch of the guidelines in September 2010.
During the first year of the implementation, the activities related to
the strengthening of malaria component of the routine supervisory
activities were initiated through the finalization of the supervisory
manuals and its limited implementation emphasizing supportive
supervision of health workers on malaria case-management
including observations of outpatient consultations. With respect
to malaria diagnostics, distribution of rapid diagnostic tests (RDT)
initiated in 2006 continued in 33 out of 149 districts, as well as on
smaller scale through the non-governmental and faith-based
organizations across the country. During the same period, malaria
microscopy, the traditional diagnostic mainstay in Kenya, was on
smaller scale supported across the country through the in-service
training of malaria microscopists and strengthening of the quality
assurance procedures. Finally, with the respect to the supply of
ACTs, the distribution of artemether-lumefantrine (AL), the
recommended first line treatment for management of uncompli-
cated malaria deployed in 2006, continued during 2010 through
the routine government supply chains.
Indicators
The rationale for the selection of key indicators was based on
those ones specified in the new national Malaria Monitoring and
Evaluation Plan 2009–2017 [7], those representing main deficien-
cies detected in past which can severely compromise the success of
the new malaria case-management policy in Kenya [9,10], and
those ones that are relatively simple to collect over short period of
time. The key indicators at health facility level included availability
of AL, other antimalarials, malaria diagnostic services, national
guidelines and basic equipment important for malaria case-
management. The key indicators at health worker level were the
proportions of health workers who received training on the new
case-management recommendations and supervisory visit includ-
ing any malaria case-management activity.
The primary study indicator was measured at the patient level
and referred to the recommended testing and treatment
management of uncomplicated malaria in line with the new
national malaria guidelines for health workers. The new guidelines
state that 1) ‘‘all patients with fever or history of fever should be tested for
malaria and only patients who test positive should be treated for malaria’’ and
that 2) ‘‘the recommended first line treatment for uncomplicated malaria in
Kenya is artemether-lumefantrine’’ [6]. To reflect criteria for testing and
AL treatment, we included febrile, non-pregnant patients weighing
5 kg and above, presenting for an initial outpatient visit without
being referred or admitted for hospitalization. Guidelines do not
specify recommended management of patients with test negative
results. Therefore, our primary indicator of correct management
was a composite performance from the malaria perspective that
included all of the following criteria: 1) patient was tested for
malaria; 2) if positive test result patient was treated with AL, and 3)
if negative test result patient was not treated for malaria. The
secondary outcomes reflected individual components of the case-
management in various patients’ subgroups including testing and
treatment based on the use and result of malaria testing.
Study design, sample size and sampling
The study design included two national, cross-sectional, cluster
sample health facility surveys. The sample size was calculated to
detect 15% change in the performance of the primary case-
management indicator between two survey rounds. The sample
size was adjusted to take into consideration clustering effect at the
health facility level and the likelihood of practices at facilities with
unavailable case-management commodities. Therefore, in order to
detect 15% difference (from conservative estimates of 50% to 65%)
with the level of confidence of 5%, power of 80%, design effect of
2, and assumption that 50% of facilities will not have either AL or
malaria diagnostic services, the estimated sample size was 680
patients below and above 5 years of age during the each survey.
Assuming that on average a minimum of 4 eligible patients will be
recruited in each age group at each facility over one survey day,
the minimum required number of surveyed facilities was 170
(680/4).
During each survey, a national representativeness was assured
drawing a stratified random sample from the universe of public
facilities and taking into consideration administrative boundaries,
type of facilities and their ownership. The following facilities were
excluded from the survey: 1) facilities from Nairobi province
requiring special studies to evaluate malaria case-management, 2)
tertiary hospitals because they serve mainly as referral facilities,
and 3) government facilities providing services to special patient
groups such as military or prisoners. In each of seven provinces
(Figure 1), four strata based on the facility type (hospitals versus
smaller facilities) and ownership (government versus faith based/
non-government) were formed. Finally, from each of the 28 strata,
a simple, random sample proportional to the number of facilities
in a stratum was drawn. A cluster was defined as all encounters
between health workers and outpatients occurring on a single
survey day.
Data collection
The health facility surveys were conducted with ten teams each
composed of three data collectors. In each team one surveyor was
a team leader and performed facility assessment and interviews
with health workers. The other two team members were student
nurses who carried out exit interviews with outpatients. The
training of data collectors and concordance testing was undertaken
over five days. On the last day of the training, a field trial of was
conducted at health facilities not included in the survey.
At each of the survey facilities data were collected over one
survey day. Data were collected using three methods. First, all
outpatients underwent rapid screening when they were leaving the
facility. Upon obtaining written informed consent, non-referred
and non-pregnant febrile patients presenting for an initial visit and
weighing 5 kg and above proceeded with the interview during
which information was collected from patient cards about malaria
diagnostics requested, results reported and medications prescribed.
During the interviews information was also collected about
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complaints, prior use of antimalarial drugs, and drug dispensing
tasks performed. Second, at each facility the availability of
antimalarial drugs, RDTs, functional malaria microscopy service,
weighing scales and job-aides, was assessed. Finally, at the end of
the working day all health workers who saw recruited patients on
the survey day were interviewed to collect information on their
demographics, pre-service training, and retrospective exposure to
in-service training and supervision. Informed written consent was
obtained for all health workers.
Data management and analysis
Data entry and cleaning was undertaken using Access (Micro-
soft, USA). All forms were entered twice by independent data
entry clerks. The analysis was performed using STATA, version 11
(StataCorp, College Station, Texas). Level estimates are presented
for each survey as proportions, with corresponding 95%
confidence intervals (CIs) adjusted for clustering at the health
facility level. Changes in proportions between baseline and follow-
up survey were tested using cluster adjusted chi-square test.
Hypothesis testing and CI estimations were done with an alpha
level of 0.05.
Descriptive analysis was undertaken at the health facility, health
worker, and patient level. First, to assess coverage and exposure to
interventions analysis was undertaken at health facility and health
worker level. Second, to assess the overall performance of the new
case-management policy practices were analyzed at patient level at
all health facilities regardless of the availability of the case-
management commodities. Third, to assess health workers
adherence to the guidelines the same analysis was restricted to
the facilities where AL and diagnostics were in stock on the day of
the survey. Fourth, since the new case-management policy does
not differ between age groups, the results are reported across all
age groups while age specific results are available upon request to
the authors.
Finally, to explore factors influencing low composite health
workers’ adherence (36%) following delivery of the interventions,
the predictors analysis examining association between malaria
testing and health facility, health worker and patient level factors
was also performed at facilities with available commodities during
the follow-up survey. Malaria testing outcome was specifically
selected since low performance of this task provided an
overwhelming contribution (78%) to non-adherent practices of
the composite performance indicator. The logistic regression using
generalized estimating equations with an independent working
Figure 1. The map of Kenya showing provincial administrative boundaries and position within Africa.
doi:10.1371/journal.pone.0024781.g001
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of the data. In the univariate analysis we first estimated odds ratios
(OR), P-values and 95% CIs for the association between health
workers’ decision to test for malaria and the following factors:
health facility type, ownership and type of available malaria
testing; health workers’ pre-service training; in-service training on
the new case-management policy; access to national malaria
guidelines; exposure to malaria supervision; patients’ caseload on
survey day; and patients’ age, temperature and main complaints.
Factors with P-value,0.15 were entered into multivariate model.
Ethics statement
Ethical approval for the study was provided by the Kenyatta
National Hospital/University of Nairobi-Ethics and Research
Committee (reference number KNH-ERC/A/383). Informed
written consent was obtained for all participants.
Results
Sample description
The baseline and follow-up surveys were respectively undertaken
between January 18–February 12, 2010 and November 8–
December 3, 2010. The baseline survey included 174 health
facilities, 224 health workers, 2,405 patients who met inclusion
criteria at all health facilities and 1,239 patients at facilities where
AL and malaria diagnostic services were available. During the
follow-up survey, 176 facilities were assessed, 237 health workers
interviewed, and respectively 1,456 and 861 patients’ consultations
meeting the same criteria were evaluated at all facilities and facilities
with AL and diagnostics in stock. During both surveys, the majority
of assessed facilities were dispensaries (70.1%vs 66.5%), followed by
health centres (18.4% vs 21.6%) and hospitals (11.5% vs 11.9%).
Similarly, during both surveys the majority of facilities were
government owned (73.0% vs 78.4%), followed by faith-based
(25.9% vs 19.3%) and non-governmental organizations (1.2% vs
2.3%). With respect to health workers, the majority during both
survey rounds were female (52.7% vs 53.2%) and nurses by cadre
(63.0% vs 64.1%). Finally, the characteristics of recruited febrile
patients were similar during both survey rounds. Most were 5 years
and older (55.5% vs 53.6%), female (56.1% vs 53.8%), reporting to
the health facility 3 days or more after the onset of illness (77.4% vs
74.0%) and without prior use of any antimalarial treatment for the
current illness (95.0% vs 95.4%). During both surveys less than 1%
of patients had completed AL dose before reporting to the facility.
No health worker, adult patient or caretaker on behalf of sick child
refused to participate in the study.
Health facility and health worker readiness to implement
new case-management policy
Table 1 presents survey levels and changes in the health facility
and health worker readiness to implement new case-management
policy. During both surveys functional weighing scales and
thermometers were present at nearly all health facilities. Just
above half of the facilities had capacity to provide parasitological
malaria diagnosis, mainly relying on malaria microscopy. There
were no significant changes in overall diagnostic capacities
between surveys (55.2% vs 58.0%; p=0.600), neither in the
provision of malaria microscopy (50.6% vs 53.4%; p=0.596) nor
in the availability of RDTs (7.5% vs 8.5%; p=0.717). Among
facilities in the districts receiving RDTs since 2007, 35.7% (10/28)
of facilities stocked RDTs during the baseline and 19.3% (6/31)
during the follow-up survey.
During the baseline survey at least one AL pack was in stock at
94.3% of facilities while the availability of weight-specific AL packs
ranged from 79.3% for 18 tablets pack to 86.2% for 24 tablets
pack. All four AL packs were in stock at 64.9% of facilities. Yet, an
increase trend, albeit statistically significant only for 6 tablets pack
(81.0% vs 89.2%; p=0.032), was observed between two surveys.
With respect to AL stock-out in 3 months prior to the surveys,
stock-out of all four AL tablet packs decreased from 27.2% to
20.6% (p=0.152) and stock out of at least one AL pack decreased
from 59.5% to 52.3% (p=0.192) (Table 1).
During the baseline survey no health worker was trained on the
new case-management policy. The follow-up survey results
showed coverage of 21.5% of trained health workers (Table 1).
With respect to the supervision, there was an increase from 41.5%
to 51.9% (p=0.026) of supervised health workers; however, the
coverage of health workers who had received a supervisory visit
that included any malaria case-management activity was low and
without significant change between two survey rounds (17.9% vs
13.9%; p=0.156). Similarly, there were no changes in the
coverage of health workers who received supervisory visit that
included observation of consultations (6.7% vs 6.8%; p=0.981).
Malaria diagnostic and treatment practices – policy
performance and health workers adherence
Table 2 shows survey levels and changes in the performance of
the composite case-management indicator and its components at
all health facilities and at facilities with available AL and malaria
diagnostics. At all facilities composite performance, defined as
patient tested for malaria and treated with AL if the test result was
positive or not treated for malaria if the test result was negative,
was low during both survey rounds. Yet, there was a significant
improvement from 15.7% at the baseline to 22.1% at the follow-
up survey (p=0.048). A similar upward trend was observed in
testing rates – from 23.9% to 30.9% (p=0.090). At facilities with
available AL and malaria diagnostics, the performance of the same
indicators was higher with a similar trend between surveys:
composite performance increased from 28.1% to 35.5%
(p=0.114) and testing rates increased from 42.5% to 49.5%
(p=0.196).
Beside low testing rates, case-management was further com-
promised with low health workers adherence to test negative
results which despite some improvement trends (47.2% vs 56.0%;
p=0.227) was suboptimal. The suggested improvements were
mainly due to a significant decline in the use of SP (10.8% vs
2.7%; p=0.022) and other than AL antimalarial treatments (6.4%
vs 0.9%; p=0.009) (Table 2). Conversely, treatment practices of
test positive patients with recommended AL were high at the
baseline and have even shown some further improvement trends
(83.3% vs 89.6%; p=0.150). Among these patients, the practice of
combining AL and quinine (AL+QN) which was present during
the baseline (10.7%) became nearly non-existent during the follow-
up survey (1.0%; p=0.002). Finally, among febrile patients who
were not tested for malaria, and therefore inappropriately
managed according to new guidelines, there was a significant
decline in the use of antimalarial drugs (63.7% vs 45.7%;
p=0.013), specifically AL (55.3% vs 42.3%; p=0.046) yet an
increased use of antibiotics (73.9% vs 82.5%; p=0.026).
Factors influencing malaria testing of febrile patients
Fifteen factors that may have influenced health workers decision
to test for malaria at facilities where diagnostics were available are
examined. Table 3 presents the multivariate model between
factors and the outcome, and univariate results for factors of
programmatic interest which did not meet the criteria for
multivariate analysis (P-value,0.15). The multivariate results
revealed significantly higher likelihood of testing practices at
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ment facilities (OR=2.43; 95% CI=1.31–4.49), at facilities with
malaria microscopy compared to those with RDTs (OR=5.95;
95% CI=1.90–18.65), at facilities with the caseload lower than 25
patients on survey day (OR=1.99; 95% CI=1.07–3.73), among
patients 5 years and older (OR=1.60; 95%: 1.05–2.45), and
among febrile patients presenting without cough (OR=1.51; 95%
CI=1.11–2.04), running nose (OR=2.10; 95% CI=1.32–3.33)
and skin problem (OR=2.55; 95% CI=1.27–5.14). No significant
association was found between the testing and exposure to the
interventions such as in-service training on the new case-
management policy (OR=0.99; 95% CI=0.48–2.05), supervisory
visit including malaria case-management (OR=1.11; 95%
CI=0.48–2.61) and access to malaria guidelines (OR=0.53;
95% CI=0.14–2.04) (Table 3).
Discussion
Universal coverage with health systems support activities and
subsequent translation of these activities into universal adherence
to the new case-management recommendations is an optimistic
target to be achieved by 2013 at the health facility level in Kenya
[7]. Our findings during 2010 identify several trends and gaps in
the case-management which are directly relevant for the
strengthening of the future implementation activities in Kenya.
Coverage with health systems support activities
Absence of stock-outs of antimalarial drugs and malaria
diagnostic services is a basic prerequisite for effective implemen-
tation of the new malaria case-management policy. Despite a
declining, though statistically non-significant, trend in AL stock-
Table 1. Levels and changes in health facility and health worker readiness to implement new case-management policy.
Baseline survey Follow-up survey P-value
n (%) 95% CI n (%) 95% CI
Health facility characteristics N=174 N=176
Availability of weighing scales 174 (100) NA 174 (98.9) 97.3–100 0.158
Availability of functional thermometer 158 (90.8) 86.5–95.1 159 (90.3) 86.0–94.7 0.882
Availability of new national guidelines 0 NA 10 (5.7) 2.2–9.1 0.001
Availability of malaria diagnostics
Functional microscopy 88 (50.6) 43.1–58.1 94 (53.4) 46.0–60.9 0.596
Non-expired malaria RDT 13 (7.5) 3.5–11.4 15 (8.5) 4.4–12.7 0.717
Any functional diagnostics 96 (55.2) 47.7–62.6 102 (58.0) 50.6–65.3 0.600
Availability of AL on survey day
At least one AL pack 164 (94.3) 90.8–97.7 171 (97.2) 94.7–99.6 0.180
AL 6 pack 141 (81.0) 75.2–86.9 157 (89.2) 84.6–93.8 0.032
AL 12 pack 139 (79.9) 73.9–85.9 152 (86.4) 81.2–91.5 0.106
AL 18 pack 138 (79.3) 73.2–85.4 144 (81.8) 76.1–87.6 0.553
AL 24 pack 150 (86.2) 81.0–91.4 153 (86.9) 81.9–92.0 0.842
All four AL packs 113 (64.9) 57.8–72.1 126 (71.6) 64.9–78.3 0.181
SP tablets 154 (88.5) 83.7–93.3 154(88.0)
a 83.1–92.9 0.883
Quinine tablets 120 (69.0) 62.0–75.9 148(84.6)
a 79.2–90.0 0.001
Quinine injections 135 (77.6) 71.3–83.8 147(84.5)
b 79.0–90.0 0.160
AL stock-out in 3 months prior to the survey
a
All four AL packs 47 (27.2)
a 20.5–33.9 36 (20.6)
a 14.5–26.6 0.152
AL 6 pack 65 (37.6)
a 30.3–44.9 53 (30.1) 23.3–37.0 0.141
AL 12 pack 76 (43.9)
a 36.5–51.4 57 (32.4) 25.4–39.4 0.026
AL 18 pack 90 (52.0)
a 44.5–59.5 74 (42.1) 34.7–49.4 0.062
AL 24 pack 68 (39.3)
a 32.0–46.6 62 (35.2) 28.1–42.4 0.431
At least one AL pack 103 (59.5)
a 52.2–66.9 92 (52.3) 44.8–59.7 0.192
Health worker characteristics N=224 N=237
Trained on new case-management policy 0 NA 51 (21.5) 16.2–26.8 ,0.001
Exposure to supervisory visit (past 3 months)
Had any type of visit 93 (41.5) 35.0–48.0 123 (51.9) 45.5–58.3 0.026
Had any visit including malaria CM 40 (17.9) 12.8–22.9 31 (13.1) 8.8–17.4 0.156
Had any visit including observations 15 (6.7) 3.4–10.0 16 (6.8) 3.5–10.0 0.981
RDT=rapid diagnostic test; AL=artemether-lumefantrine; CM=case management; NA=not applicable.
aDenominator does not include 1 health facility with missing value.
bDenominator does not include 2 health facilities with missing values.
doi:10.1371/journal.pone.0024781.t001
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52% for at least one AL pack) the stock-out levels during 2010
were still substantial. This is of particular concern for simultaneous
absence of all four AL packs which precludes effective treatment
and is likely to be associated with increased childhood mortality as
shown in Western Kenya [11]. Yet, ACT stock-outs revealed in
our study are not unique reports – they had been reported from
Uganda [12], Zambia [13], Nigeria [14], Sudan [15], Tanzania
[16], Senegal [17], and indeed in the previous smaller studies in
Kenya [10]. Similarly to AL availability, no significant changes
were observed during 2010 in the capacity of health facilities to
provide parasitological diagnosis resulting in an overall gap of 42%
of facilities unable to provide either malaria microscopy or RDT
diagnostic services. The findings on malaria diagnostic capacities
in Kenya are not surprising given that these services are largely
dependent on microscopy which is predominantly available at
higher level facilities; however what is worrisome is that over two-
thirds of facilities lacked RDTs in areas where RDTs had been
supplied since 2006.
The investigations of the causes of commodity stock-outs are
beyond the scope of this study and they deserve qualitative and
quantitative examinations of the complete supply chain to
comprehensively address these problems and ensure effective
distribution systems. Yet, while further studies, programmatic
strengthening of the supply chain including redistribution of stocks
at peripheral level, and piloting of innovative approaches to
eliminate ACT stock-outs such as recently demonstrated in
Tanzania [18] should remain a priority, we also emphasize that
rational use of antimalarial drugs based on malaria diagnostics
must be viewed as an integral component of this process.
Table 2. Levels and changes in key diagnostic and treatment indicators - performance of the new case-management policy
(analysis at all health facilities) and health workers adherence to guidelines (analysis at facilities with available diagnostics and AL).
Baseline survey Follow-up survey P-value
n (%) 95% CI n (%) 95% CI
Policy performance N=2,405 N=1,456
Correctly managed
a 378 (15.7) 12.0–19.4 321 (22.1) 16.7–27.3 0.048
Malaria test performed 575 (23.9) 18.9–28.9 450 (30.9) 24.4–37.4 0.090
Test positive treated with AL
b 244 (82.7) 75.8–89.6 189 (89.2) 84.2–94.1 0.127
Test negative not treated with AM
c 97 (34.6) 25.2–44.1 95 (39.9) 30.5–49.3 0.260
Health workers adherence N=1,239 N=861
Correctly managed
a 348 (28.1) 22.6–33.6 306 (35.5) 27.8–43.3 0.114
Malaria test performed 526 (42.5) 35.9–49.0 426 (49.5) 40.9–58.0 0.196
Treatment for test positive N=276 N=201
AL 230 (83.3) 76.1–90.5 180 (89.6) 84.5–94.6 0.150
AL+QN 29 (10.5) 4.8–16.2 2 (1.0) 0–2.4 0.002
Other antimalarial
d 15 (5.4) 1.6–9.2 14 (7.0) 2.3–11.6 0.607
No antimalarial prescribed 2 (0.7) 0–1.8 5 (2.5) 0.2–4.8 0.153
Antibiotic prescribed 176 (63.8) 55.3–72.2 123 (61.2) 50.8–71.6 0.699
Treatment for test negative N=250 N=225
AL 89 (35.6) 25.6–45.6 91 (40.4) 30.8–50.1 0.489
SP 27 (10.8) 2.6–19.0 6 (2.7) 0.1–5.2 0.022
Other antimalarial
e 16 (6.4) 2.3–10.5 2 (0.9) 0–2.1 0.009
No antimalarial prescribed 118 (47.2) 37.0–57.4 126 (56.0) 45.7–66.3 0.227
Antibiotic prescribed 212 (84.8) 79.0–90.6 175 (77.8) 72.9–82.7 0.082
Treatment when test not done N=713 N=435
AL 394 (55.3) 46.7–63.8 184 (42.3) 32.8–51.8 0.046
Other antimalarial
f 60 (8.4) 4.3–12.5 15 (3.5) 0.1–6.8 0.095
No antimalarial prescribed 259 (36.3) 27.8–44.8 236 (54.3) 43.1–65.4 0.013
Antibiotic prescribed 527 (73.9) 68.4–79.4 359 (82.5) 77.4–87.7 0.026
AL=artemether-lumefantrine; AM=antimalarial; QN=quinine; SP=sulfadoxine-pyrimethamine; AS=artesunate; AQ=amodiaquine; DHA=dihydroartemisinin;
ART=artemether.
aDefined as management of febrile patient meeting all of the following three criteria: 1) patient tested for malaria; 2) if positive test result treated with AL, and 3) if
negative test not treated for malaria.
bDenominators in this category include 295 patients at baseline and 212 at follow-up surveys.
cDenominators in this category include 280 patients at baseline and 238 at follow-up surveys.
dOther antimalarial treatment include QN (18), SP (3), AS+AQ (2), DHA (2), QN+SP (2), ART (1) and AL+SP (1).
eOther antimalarial treatment include AL+QN (8), QN (6), AQ (3) and AL+SP (1).
fOther antimalarial treatment include AL+QN (28), SP (28), QN (14), AQ (4) and DHA (1).
doi:10.1371/journal.pone.0024781.t002
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necessary to implement, reinforce and maintain health workers’
practices according to the case-management standards include
provision of in-service training, guidelines and effective supervisory
visits. Our findings revealed low coverage of these activities by the
end of 2010; however, this was not a surprising finding and not in
discordance with reports from several large scale evaluations at
various stages of implementation process in other African
countries [13,14]. First, despite a national character of the
training, 22% of trained health workers after the completion of
the training programme correspond to the training capacities to
cover 4,807 health workers within the universe of approximately
20,000 front-line health workers countrywide. Second, low access
to the new national guidelines by the end of 2010 is due to lack of
harmonization between the training implementation and guideline
dissemination where the training, though based on new guidelines
recommendations, took place prior to the printing and distribution
of the guidelines. However, it was worrisome to observe that
despite the majority of health workers receiving supervision, any
malaria case-management activity was rarely a component of this
activity. This is especially unfortunate given that the training was a
nationwide and the routine supervision could have been a channel
to reinforce translation of training messages into the clinical
practice.
Malaria case-management practices
We hypothesized that 15 percentage points is a minimum case-
management improvement we would like to observe between two
survey rounds to be able to substantially reduce the gap by 2013.
Our findings revealed that during 2010 the policy performance
increased from 16% to 22% of febrile patients managed according
to the new guideline. While low performance rate at all study
Table 3. Predictors of health workers decision to test febrile patients for malaria.
Predictors No of consultations
No (%)
tested
OR
(95% CI) P-value
Multivariate results
Ownership of facility
Faith based or non-governmental 98 78 (79.6) 2.43 (1.31–4.49) 0.005
Government 763 348 (45.6) 1.0 (Ref.)
Type of malaria diagnostics at facility
Microscopy 822 417 (50.7) 5.95 (1.90–18.65) 0.002
Rapid diagnostic test 39 9 (23.1) 1.0 (Ref.)
Caseload on survey day
#25 patients 355 216 (60.9) 1.99 (1.07–3.73) 0.031
.25 patients 506 210 (41.5) 1.0 (Ref.)
Age of patient
5 years and older 441 263 (59.6) 1.60 (1.05–2.45) 0.031
Below 5 years 420 163 (38.8) 1.0 (Ref.)
Cough main complaint
Absent 493 278 (56.4) 1.51 (1.11–2.04) 0.008
Present 368 148 (40.2) 1.0 (Ref.)
Running nose main complaint
Absent 778 401 (51.5) 2.10 (1.32–3.33) 0.002
Present 83 25 (30.1) 1.0 (Ref.)
Skin problem main complaint
Absent 817 413 (50.6) 2.55 (1.27–5.14) 0.009
Present 44 13 (29.6) 1.0 (Ref.)
Univariate results
a
HW trained on new case-management policy
Yes 211 104 (49.3) 0.99 (0.48–2.05) 0.979
No 650 322 (49.5) 1.0 (Ref.)
HW had supervisory visit including malaria
Yes 188 97 (51.6) 1.11 (0.48–2.61) 0.803
No 673 329 (48.9) 1.0 (Ref.)
HW has access to guidelines
Yes 29 10 (34.5) 0.53 (0.14–2.04) 0.353
No 832 416 (50.0) 1.0 (Ref.)
HW=health worker.
aOnly selected variables of programmatic importance are presented.
doi:10.1371/journal.pone.0024781.t003
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nearly half of the facilities, at the facilities with available diagnostic
services and AL, the performance of the same indicator, despite an
increase of 8% between two survey rounds, remained however low
(36%).
There are three levels of non-adherent health workers’ practices
resulting in poor performance of the composite indicator at
facilities where commodities are available. First, the major
discordance is related to low testing rates contributing currently
to 78% of non-adherent practices. An increase in testing rates for
febrile patients from 43% to 50% could be seen as an
improvement trend, and indeed testing is higher than observed
in larger scale evaluations in other countries [19–22] yet it is
substantially lower than what was shown that can be achieved in
Senegal [16] or under the smaller scale operational conditions in
other countries [23,24]. Second, despite a declining, yet
statistically non-significant trend from 56% to 47% of patients
with negative test results who are treated with an antimalarial,
nearly half of the patients in this category are still treated in
discordance with national guidelines. Recently, studies have shown
that intensive interventions, including high quality of in-service
training supported with supervision and strengthened monitoring
and surveillance, can substantially improve adherence to test
negative results [23–27]. However, as reported from a number of
countries, and concurring with our findings, the adherence
challenges remain under both, microscopy and RDT diagnostic
strategies, when routine programmatic interventions are evaluated
on larger scale and in less controlled conditions [20–22,28–31].
Several studies have also reported that an important component
facilitating health workers’ adherence to test negative results is
development and implementation of guidelines for management of
non-malaria febrile illness [23,32]. Despite a standardization of
guidelines and manuals during 2010 this is a still pending
component of the case-management activities in Kenya that
should be addressed as part of collaborative efforts between
different national programmes. Third, we are glad to report that
six years following the change of treatment policy, the lowest
discordance was found in patients group with positive test result
where use of recommended AL treatment reached 90% at the end
of 2010 and non-adherent treatment practices observed in prior
years [33,34], and up to certain extent during the baseline survey,
became very rare.
Predictors of health workers decision to test patients for
malaria
Beside the absence of malaria testing services, non-adherence to
testing recommendations where diagnostics are available present a
major impediment compromising performance of the new case-
management-policy. Our predictors analysis brings an additional
light on factors influencing health workers’ testing practices.
Importantly, we observed that exposure to in-service training on
the new recommendations, supervision and guidelines have not
influenced testing practices. The in-service training for health
workers, as the main case-management implementation activity
during 2010, deserves attention. The deficiencies and limited
effectiveness of stand-alone in-service trainings were previously
reported in Kenya [35,36] and in other parts of Africa [12,29]. In
2010 the suboptimal training’s effect could be attributed to the
uncertain quality of the training implementation, absence of post-
training follow-up component, qualitative and quantitative
deficiencies of supportive supervision at health facilities to
reinforce practices, and implementation of the training prior to
the distribution of the new guidelines.
Yet, several other factors influenced health workers decision to
test for malaria. First, patients were twice more likely to be tested at
facilities with lower caseload, the finding also observed recently in
Angola [22]. Second, patients were six times more likely to be tested
at facilities with malaria microscopy compared to those providing
RDTs - the finding suggesting health workers preference for
microscopy or possible lack of trust in RDT based malaria
diagnosis. Third, testing was more common for patients above 5
years of age, what is likely a reflectionof long term policy promoting
presumptive treatment in young children. Fourth, patients at faith
based facilities were more likely to be tested than in government
owned, what may be due to more established cost-recovery schemes
at these facilities with higher testing charges attracting economically
wealthier patients. Finally, patients presenting with fever but
without complaints of cough, running nose and skin problem were
also more likely to be tested. The findings may suggest health
workers’ intention to rule out malaria in febrile patients on clinical
grounds, however the practice deemed inappropriate since it is
inconsistent with Kenyan guidelines, the prior research showing
lack of clinical algorithms to reliably rule out malaria [37–39], and
finally with this study context where 39–44% of febrile patients who
were tested and presented with cough, running nose and skin
problem were alsopositiveformalaria (data available upon request).
Conclusion
The findings at the end of the first year of the implementation
process, and two years before midterm evaluation of the 2009–
2017 NMS, suggest that most of the key indicators have shown
some improvement trends, however the differences observed were
smaller than expected, rarely statistically significant, and resulting
for the majority of the indicators in a substantial coverage and
performance gap to be bridged in the next two years. To reduce
case-management gaps towards 2013 targets, the opportunity lies
in the forthcoming scale-up of RDTs, however the success of the
activity will be critically dependent upon the delivery of a
comprehensive case-management package. The minimum content
of this package should include high quality of the training focusing
on the deficiencies highlighted in this study, alignment of the
training with RDT distribution, and importantly translation of
stand-alone activities into post-training follow-up, improved
quantity and quality of the supervisory visits, and more intense
routine monitoring at district level able to overcome inherited
barriers and weaknesses of the health systems. Failure to deliver
comprehensive package of case-management interventions would
risk leaving an important gap towards the optimistic targets.
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